JRC News

  1. 17 May 2016

    EURL ECVAM releases its report on extrapolation approaches to avoid chronic fish toxicity testing on the basis of existing aquatic toxicity data.

  2. 4 May 2016

    European experts in alternative approaches to animal testing promote current and future collaborations with partners in Brazil.

  3. 19 Apr 2016

    Nanoform, Read-across, Weight of Evidence…what do they mean in the nanomaterials safety context? How many definitions of those terms are available?

    Consistent use of terminology is important in any field of science and technology to ensure common understanding of concepts and tools among different stakeholders, such as science experts, regulatory authorities, industry and consumers.

  4. 15 Apr 2016

    Highlights include the launch of the European Smart Specialisation Platform on Energy, opening of the Disaster Risk Management Knowledge Centre and the launch of the European Interoperability Laboratory for Electric Vehicles and Smart Grids.

  5. 12 Apr 2016

    The European Commission has appointed Ms Maive Rute as Deputy Director-General of the Joint Research Centre.

  6. 7 Apr 2016

    The focus of World Health Day on April 7 is diabetes, a disease which affects about 32 million people in the EU. The JRC supports the efforts to combat diabetes through its nutrition and health related activities, with special focus on children and adolescents. JRC scientists have recently developed a new reference material for the monitoring of diabetes markers in blood.

  7. 22 Mar 2016

    "Legal highs" are new psychoactive substances (NPS) with similar - and sometimes stronger- effects than illicit drugs such as cannabis, heroin and cocaine. They can be cheaply and easily produced and they have recently gained popularity even amongst casual drug users, often teenagers and young adults, therefore becoming a serious new threat to public health.

  8. 17 Mar 2016

    The use of nanotechnology in healthcare promises new diagnostic opportunities and innovative therapeutic concepts that may help to tackle major medical challenges such as cancer, neurodegenerative diseases and antimicrobial resistance.

     

    However, the manufacturing process of nanomedicines is sophisticated, and quality inconsistencies between batches must be carefully monitored before clinical applications can be considered. Furthermore, safety concerns related to the use of nanomaterials must be addressed as early as possible during product development.

  9. 17 Mar 2016

    Following the most recent call for interest in 2015, the network has been recently expanded to include 38 member facilities.

  10. 14 Mar 2016

    Research data produced by the JRC or in cooperation with other partners is now publicly available, in support of the European Commission’s strategy on Open Science for improved circulation of knowledge and thus innovation for generating growth.